#Drug Safety and Recalls

Articles tagged "Drug Safety and Recalls"

Gabapentin Linked to Dementia Risk: What Pharmacists Need to Know
Clinical Practice

Gabapentin Linked to Dementia Risk: What Pharmacists Need to Know

New research reveals concerning links between gabapentin use in chronic pain patients and increased dementia risk. Essential reading for pharmacists and healthcare providers.

FDA Removes REMS Program for Clozapine Despite Neutropenia Risk
News

FDA Removes REMS Program for Clozapine Despite Neutropenia Risk

FDA eliminates mandatory safety program for clozapine, citing access concerns while acknowledging ongoing neutropenia risk for patients.